Login to Your Account

Other News To Note

Friday, November 4, 2011

• Active Biotech AB, of Lund, Sweden, and Teva Pharmaceutical Industries Ltd., of Jerusalem, reported that following a meeting with the FDA, Teva determined it would be premature to file a new drug application for multiple sclerosis drug laquinimod, and that the FDA has offered to work with Teva to determine the best design for conducting an additional trial.

• Aslan Pharmaceuticals Pte Ltd., of Singapore, is partnering with Bristol-Myers Squibb Co., of New York, to accelerate the development of BMS

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription